HOXB13 and invasive breast carcinoma: To conclude, in our large study consisting of 68,521 invasive breast cancer cases and 54,865 controls from 81 BCAC studies we provide strong evidence that the rare, but recurrent HOXB13 germline mutations p.G84E and p.R217C are not associated with an increased risk to develop breast cancer.